Numerous studies have indicated that KLF4 overexpression predicts a better prognosis in several malignancies, including prostate cancer, colon cancer, urothelial cancer and gastric cancer [14, 15, 40–41]. This evidence concerns the gene KLF4 and prostate carcinoma.